HKTDC Media Room HKTDC Media Room

Press conference to introduce inaugural Asia Summit on Global Health

Promoting development and investment in life and health innovation

(Changes are highlighted in yellow)


16 November 2021 Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (ASGH) will take place on 24 November 2021 at the Hong Kong Convention and Exhibition Centre (HKCEC) in a hybrid format, offering both online and in-person participation.


Running on the theme “Shaping a Resilient and Sustainable Future”, the summit aims at building an international investment and business exchange platform to promote dialogue and collaboration between the biotech, medical and healthcare sectors in Hong Kong, Mainland China and across the globe, and to explore investment opportunities. The summit will also highlight Hong Kong’s advantages as a scientific research and business platform for the medical and healthcare sectors. Speakers from around the world, including senior government officials, investors, influential business leaders, financial and professional service providers, as well as renowned academics from related sectors, will participate in the event.


Margaret Fong, Executive Director of the HKTDC, will be joined by business leaders as well as medical and health experts to host a press conference on 17 November, announcing details of the summit and its speakers and sharing on the importance of development and investment in life and health technology.


We cordially invite you or your representatives to attend the press conference. Details are as follows:



17 November 2021 (Wednesday)


2:30pm to 3:30pm


Room S224-S225, 2/F, Old Wing, Hong Kong Convention and Exhibition Centre, 1 Expo Drive, Wan Chai


  • Margaret Fong, Executive Director, HKTDC
  • Alan Au, Director, HK Bio-Med Innotech Association; Founder and Managing Partner, GT Healthcare Capital Group
  • Tony Mok, Co-founder, Sanomics Limited; Board of Directors of AstraZeneca, HutchMed and Sanomics


The press conference will be conducted in English with a Cantonese and Mandarin simultaneous translation service provided. (Note: This simultaneous translation is for reference only. In the event of discrepancies, the English version shall prevail.)


The summit features over 70 health experts and business leaders from across the globe as speakers, including (in alphabetical order according to family name):



The ASGH will cover a number of forward-looking topics, including the latest developments of healthtech, biotechnology and digital health, the prospects for the healthcare industry in the mainland (particularly the GBA), ASEAN countries and other Asian nations, as well as Hong Kong's advantages as a biotech listing hub. This will help industry participants to explore business opportunities and options in sustainable development. Other key features of the summit are Deal Flow Matchmaking for healthcare projects and investors, the InnoHealth Showcase and exhibition, which will present cutting-edge technologies from about 100 start-ups and international projects, healthcare enterprises and related organisations, and various other activities, both online and onsite, to encourage business exchange and collaboration among the global participants.


Members of the media interested in interviewing the speakers can send an email to or by 22 November 2021.


Media enquiries

Please contact the HKTDC’s Communication and Public Affairs Department:

Sunny Ng                  Tel: (852) 2584 4357           Email:

Sam Ho                     Tel: (852) 2584 4569           Email:


Yuan Tung Financial Relations:

Agnes Yiu                 Tel: (852) 3428 5690           Email:

Hing-fung Wong       Tel: (852) 3428 3122           Email:



ASGH website:



Download Programme